Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.
揭示了新型
MCH-1受体
拮抗剂。这些化合物用于治疗各种疾病,包括肥胖、焦虑、抑郁、非
酒精性
脂肪肝病和精神疾病。本发明还描述了制备这些化合物的方法。